Tuesday, January 04, 2022 9:06:02 PM
I like the genre because I did well with one of my picks, so I was an early buyer of RGBP when it was a youngster under the tutelage of BioMatrix! I sold out after Biomatrix left town, but bought right back in when I saw that rgbp Had found a place to continue their work! It is going anywhere now as far as the PPS goes, but they have patents of a high order, with some in the lengthy clinical trial phase! Once the GENERAL CANCER Vaccine finishes-up in its clinical trial, it should start to see some revenue?
MCET did OK for a while, but it started to stall some time ago for reasons unknown to me, so I didn't buy in just because it drifted to cheap Man's land! Just because it was a BioPharma co' was of no value to me, only results mattered! I wish them well and hope they can resurrect some of those promising Treatments or Vaccines, as they show hope? Look up (BRCHF) Artificial Intelligence Stock, you might like it? But don't buy in until you know all the facts, and there are many! Gl in 2022!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM